Get Involved

Increase Appropriations to the National Institute on Aging - Division of Aging Biology

By signing this petition, you support increasing the budget for the NIA-DAB to ensure the resources necessary to advance aging biology and geroscience research.

The Issue

The National Institute on Aging’s Division of Aging Biology (NIA-DAB) receives less than 1% ($440 million) of the total NIH budget ($48 billion), despite being at the forefront of research into the biological mechanisms of aging and age-related diseases. This limited funding constrains its ability to support innovative projects that could revolutionize how we address the challenges of health and aging.

Increased funding for the NIA-DAB would accelerate groundbreaking discoveries, foster innovative private and public collaborations, and drive the development of therapies to improve healthspan, reduce healthcare costs, and enhance quality of life for millions of Americans.

By signing this petition, you support increasing the budget for the NIA-DAB to ensure the resources necessary to advance aging biology and geroscience research. Together, we can transform the future of public health and aging.

Sign this petition

Carlo Tanratore

Georgetown University

Dr. Tornatore is the Regional Chief of Neurology for MedStar Health and Chairman and Neurologist-in-Chief in the Department of Neurology at MedStar Georgetown University Hospital. He is also the Executive Director of the Multiple Sclerosis Patient Centered Specialty Practice­ MedStar Georgetown and Professor and Chairman in the Department of Neurology at Georgetown University Medical Center. Dr. Tornatore received his undergraduate degree in neurobiology from Cornell University and then attended Georgetown University School of Medicine where he received his medical degree. Following a Neurology Residency at Georgetown University Hospital, he was a post-doctoral fellow at the National Institute of Neurologic Disorders and Stroke at the National Institutes of Health. Dr. Tornatore has published extensively in the areas of neuroimmunology, neurovirology and Multiple Sclerosis and is currently involved in over 15 clinical trials for the treatment of Multiple Sclerosis. He has won multiple awards in the areas of medical student teaching, patient care and scholarly research.